by Ian Lipman | Mar 16, 2023 | News
Client News OKYO Pharma: Announces Phase 2 Trial of OK-101 Drug to Treat Dry Eye Disease is now listed on the ClinicalTrials.gov Public Website. Home / Client News / OKYO Pharma: Announces Phase 2 Trial of OK-101 Drug to Treat Dry Eye Disease is now listed on the...
by Ian Lipman | Mar 15, 2023 | News
Client News Hot Rocks Investments PLC: Notice of Annual General Meeting Home / Client News / Hot Rocks Investments PLC: Notice of Annual General Meeting The Company’s AGM will be held at Shakespeare Martineau LLP 6th Floor, 60 Gracechurch Street, London, United...
by Ian Lipman | Mar 15, 2023 | News
Client News Okyo Pharma Limited: Grant of options -PDMR dealing Home / Client News / Okyo Pharma Limited: Grant of options -PDMR dealing London, March 15, 2023 – OKYO Pharma Limited (Nasdaq: OKYO; LSE: OKYO) (“OKYO” or the “Company”), an...
by Ian Lipman | Mar 15, 2023 | News
Client News Sovereign Metals Limited: Kasiya Graphite Global Warming Potential Among Lowest in Industry Home / Client News / Sovereign Metals Limited: Kasiya Graphite Global Warming Potential Among Lowest in Industry KASIYA’S GRAPHITE GLOBAL WARMING POTENTIAL TO...
by Ian Lipman | Mar 14, 2023 | News
Client News Upland Resources Limited: Sarawak UBO Appointments & Operational Update Home / Client News / Upland Resources Limited: Sarawak UBO Appointments & Operational Update Upland Resources Limited (LSE: UPL) is pleased to announce the appointment of...
Recent Comments